Goldman Sachs

Bicycle Therapeutics (NASDAQ:BCYC) Lifted to “Buy” at Goldman Sachs Group | 9/15/2019

Bicycle Therapeutics (NASDAQ:BCYC) Lifted to “Buy” at Goldman Sachs Group Posted by John Perry on Sep 14th, 2019 Tweet Goldman Sachs Group upgraded shares of Bicycle Therapeutics (NASDAQ:BCYC) from a neutral rating to a buy rating in a report issued on Wednesday morning, BenzingaRatingsTable reports. They currently have $14.00 price target on the stock. Several other analysts have also recently commented on the company. Zacks Investment Research cut …

Apple Inc. (NASDAQ:AAPL) price target lowered to $165.00 by Goldman Sachs Group | 9/13/2019

Analyst Ratings For Apple Inc. (NASDAQ:AAPL) Story continues below Today, Goldman Sachs Group lowered its price target on Apple Inc. (NASDAQ:AAPL) to $165.00 per share. There are 22 Buy Ratings, 18 Hold Ratings, 4 Sell Ratings, 1 Strong Buy Ratings on the stock. The current consensus rating on Apple Inc. (NASDAQ:AAPL) is Hold with a consensus target price of $217.3514 per share, a potential 0.25% downside. Some …

Follow Goldman Sachs:    

Bayer (FRA:BAYN) PT Set at €77.00 by Goldman Sachs Group | 9/13/2019

Bayer (FRA:BAYN) PT Set at €77.00 by Goldman Sachs Group Posted by Amber Abramson on Sep 12th, 2019 Tweet Bayer (FRA:BAYN) has been assigned a €77.00 ($89.53) price target by analysts at Goldman Sachs Group in a research report issued to clients and investors on Wednesday, August 21st, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the healthcare company’s stock. Goldman Sachs Group’s price objective …

Zoetis (NYSE:ZTS) Now Covered by Analysts at Goldman Sachs Group | 9/13/2019

Goldman Sachs Group started coverage on shares of Zoetis (NYSE:ZTS) in a research report released on Monday, The Fly reports. The firm issued a conviction-buy rating and a $145.00 target price on the stock. Several other research firms have also recently issued reports on ZTS. SunTrust Banks raised their price objective on shares of Zoetis from $120.00 to $130.00 and gave the stock a hold rating in a …

Elanco Animal Health (NYSE:ELAN) Coverage Initiated by Analysts at Goldman Sachs Group | 9/13/2019

Goldman Sachs Group started coverage on shares of Elanco Animal Health (NYSE:ELAN) in a research note released on Monday morning, The Fly reports. The firm issued a positive rating on the stock. The analysts noted that the move was a valuation call. Several other research firms have also issued reports on ELAN. UBS Group upgraded shares of Elanco Animal Health from a sell rating to a neutral rating and …

Covetrus (NASDAQ:CVET) Coverage Initiated by Analysts at Goldman Sachs Group | 9/13/2019

Goldman Sachs Group began coverage on shares of Covetrus (NASDAQ:CVET) in a research note published on Monday, 24/7 WallStreet reports. The firm issued a sell rating and a $11.00 target price on the stock. Several other brokerages have also recently issued reports on CVET. Stifel Nicolaus reduced their price objective on Covetrus from $30.00 to $18.00 and set a hold rating on the stock in a research note on …

Goldman Sachs Group Analysts Give Novartis (VTX:NOVN) a CHF 105 Price Target - American Banking News | 9/13/2019

Posted by ABMN Staff on Sep 13th, 2019 // No Comments Novartis (VTX:NOVN) has been assigned a CHF 105 target price by investment analysts at Goldman Sachs Group in a report issued on Friday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. A number of other equities analysts also recently weighed in on NOVN. Deutsche Bank set a CHF 90 price target on Novartis and …

Goldman Sachs Group Reiterates CHF 105 Price Target for Novartis (VTX:NOVN) | 9/13/2019

Goldman Sachs Group Reiterates CHF 105 Price Target for Novartis (VTX:NOVN) Posted by Tristan Rich on Sep 13th, 2019 // Comments off Novartis (VTX:NOVN) received a CHF 105 price target from equities researchers at Goldman Sachs Group in a report issued on Friday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Several other analysts also recently weighed in on the company. JPMorgan Chase & Co …

Koninklijke Philips (AMS:PHIA) PT Set at €41.50 by Goldman Sachs Group | 9/13/2019

Goldman Sachs Group set a €41.50 ($48.26) target price on Koninklijke Philips (AMS:PHIA) in a research note issued to investors on Monday, Borsen Zeitung reports. The firm currently has a buy rating on the stock. Several other research firms have also recently commented on PHIA. Credit Suisse Group set a €42.00 ($48.84) target price on Koninklijke Philips and gave the company a neutral rating in a research report on …

A Verizon executive is joining Goldman Sachs as chief technology officer as the Wall Street bank reshuffles its ranks | Business Insider | 9/12/2019

… partnership is now around 450 people. Solomon has been trimming those ranks and making the partnership more exclusive, including leaning towards individuals who are in revenue-producing roles. To be sure, the rank of Goldman Sachs partner is still one of the most sought after titles on Wall Street, largely for the wealth it can bring. Goldman has also been hiring more for partners and other senior-level roles from …

Goldman Sachs Group Begins Coverage on Zoetis (NYSE:ZTS) - Dakota Financial News | 9/12/2019

Goldman Sachs Group Begins Coverage on Zoetis (NYSE:ZTS) Posted by Adam Masters on Sep 12th, 2019 // Comments off Goldman Sachs Group began coverage on shares of Zoetis (NYSE:ZTS) in a report released on Monday morning, The Fly reports. The brokerage issued a conviction-buy rating and a $145.00 target price on the stock. Several other brokerages have also recently weighed in on ZTS. Bank of America cut Zoetis …

Goldman Sachs Group Begins Coverage on Covetrus (NASDAQ:CVET) | 9/12/2019

Goldman Sachs Group initiated coverage on shares of Covetrus (NASDAQ:CVET) in a research note issued to investors on Monday morning, 24/7 WallStreet reports. The firm issued a sell rating and a $11.00 price objective on the stock. Several other equities research analysts have also commented on CVET. ValuEngine lowered Covetrus from a buy rating to a hold rating in a research note on Tuesday, August 13th. Zacks Investment Research …

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €80.00 Price Target at Goldman Sachs Group | 9/12/2019

Goldman Sachs Group set a €80.00 ($93.02) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Monday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock. FME has been the topic of a number of other reports. Jefferies Financial Group set a €68.00 ($79.07) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock …

Goldman Sachs Group Analysts Give Fresenius Medical Care AG & Co. KGaA (ETR:FME) a €80.00 Price Target | 9/12/2019

Goldman Sachs Group set a €80.00 ($93.02) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note released on Monday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock. Other research analysts have also issued reports about the stock. Berenberg Bank set a €89.95 ($104.59) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock …

Goldman Sachs Group Reiterates “€53.00” Price Target for Fresenius SE & Co KGaA (FRA:FRE) | 9/12/2019

Goldman Sachs Group set a €53.00 ($61.63) price objective on Fresenius SE & Co KGaA (FRA:FRE) in a research note released on Monday morning, firm currently has a buy rating on the stock.A number of other research analysts have also weighed in on FRE. Morgan Stanley set a €50.00 ($58.14) price objective on Fresenius SE & Co KGaA and gave the stock a neutral rating in a report on Wednesday, May …

Kraft Heinz Announces the Expiration and Results for Tender Offer for Any and All 5.375% Senior Notes Due 2020 | Business Wire | 9/11/2019

PITTSBURGH & CHICAGO- The Kraft Heinz Company (“Kraft Heinz”) (Nasdaq: KHC) announced today that the previously announced offer to purchase for cash (the “Offer”) commenced by its 100% owned subsidiary Kraft Heinz Foods Company (the “Issuer”) for any and all of its outstanding 5.375% senior notes due 2020 (the “Notes”) expired at 5:00 p.m., New York City time, on September 9, 2019 (the “Expiration Time”). As of the Expiration Time, $494,998,000 …

Kraft Heinz Commences Cash Tender Offer for Up To $1 Billion Aggregate Purchase Price of Certain of its Outstanding Notes | Business Wire | 9/11/2019

… 794-2200 (toll free) or +1 212-430-3774 (for banks and brokers). Questions regarding the terms of the Tender Offer should be directed to BofA Merrill Lynch at (980) 387-3907 (toll free) or (888) 292-0070 (collect), Citigroup at (800) 558-3745 (toll free) or (212) 723-6106 (collect), Goldman Sachs & Co. LLC at (800) 828-3182 (toll free) or (212) 357-0215 (collect) or J.P. Morgan at (866) 834-4666 (toll free) or (212) 834-8553 (collect). Neither …

LexinFintech Announces US$300 Million Private Placement of Convertible Notes with PAG | PR Newswire | 9/11/2019

SHENZHEN, China LexinFintech Holdings Ltd. (NASDAQ: LX ) (“Lexin” or the “Company”), a leading fintech platform for educated young adults in China , today announced that it has entered into a convertible note purchase agreement with PAG, a leading Asia -focused private equity firm with over US$30 billion in capital under management, pursuant to which the Company will issue and sell convertible notes in an aggregate principal amount of US$300 …

Elanco Animal Health (NYSE:ELAN) Now Covered by Goldman Sachs Group - Modern Readers | 9/11/2019

Analysts at Goldman Sachs Group started coverage on shares of Elanco Animal Health (NYSE:ELAN) in a report issued on Monday, The Fly reports. The brokerage set a “positive” rating on the stock. The analysts noted that the move was a valuation call. Other research analysts also recently issued research reports about the company. UBS Group upgraded Elanco Animal Health from a “sell” rating to a “neutral” rating and reduced …

A 9% Secret Income Stream—from Goldman Sachs? | 9/11/2019

This article reveals how retail investors can unlock a 9% “secret income stream” from Goldman Sachs. It’s completely legal, but most have never heard of it. Goldman Sachs BDC content/uploads/2019/09/Heres-a-9-Secret-Income-Stream-From-Goldman-Sachs-150x150.jpg A 9% Secret Income Stream—from Goldman Sachs? By Jing Pan, B.Sc., MA iStock.com/2jenn A High-Yield Opportunity Most People Have Never Heard of Whether you …

AMA

Billionaire David Koch dies at 79 | Yahoo News | 8/24/2019

… mate with Ed Clark. They received roughly 1% of the vote. Koch has been targeted by Democratic politicians like President Obama for his involvement in politics, accusing Koch of buying elections and having too much … Koch Industries’ annual sales are larger than that of Facebook, Goldman Sachs, and U.S. Steel combined. And it’s not just the size of the company, I think, that makes it important; it’s the scope of …

AllianceBernstein National Municipal Income Fund Releases Monthly Portfolio Update | PR Newswire | 8/24/2019

… Massachusetts School Building Authority (Massachusetts School Building Authority Sales Tax) Series 2011B 5.00%, 10/15/32 2.03% 4) Central Plains Energy Project (Goldman Sachs Group, Inc. (The)) Series 2017A 5.00%, 9/01/42 1.93% 5) Jefferson County Board of … 6.04% Connecticut 5.36% Florida 4.25% South Carolina 3.04% Massachusetts 2.43% Alabama 2.38% Nebraska 1.93% Wisconsin 1.63% North Carolina 1.58% Minnesota 1.47% Oklahoma 1.46% Tennessee 1.19% Utah 1.18% Hawaii 1.16% Colorado 1.11% Maryland 1.09% District of …

ACA

This Week In Credit Card News: Why Card Issuers Offer Streaming Rewards; An Amazon Cryptocurrency? | Forbes | 8/23/2019

… Realist ] Here’s How The New Apple Card Could Put Pressure on Verizon and AT&T Apple’s new credit card with Goldman Sachs could be a disruptive force in more than just the banking industry. The … while student loan debt declined $8 billion to $1.48 trillion. [ ACA International ] Mobile Banking Apps in the UK are Surging Ahead of Investment and Insurance Apps Over three-quarters of consumers in the UK use …

Iris Dorbian wrote a new post, NMS-backed Cordental acquires Franklin, Tennessee dental practice, on the site PE Hub | 8/20/2019

… Tennessee College of Dentistry and served six years in the U.S. Army Dental Corps. He is a fellow in the Academy of General Dentistry (AGD) and is one of four dentists in Tennessee to be … spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies …

ACO

Stocks making the biggest moves premarket: Canada Goose, Tilray, RealReal, Qualcomm, CBS & more | CNBC | 8/14/2019

… going forward. CBS – CBS was downgraded to “underperform” from “outperform” at Bernstein, following the announcement of its planned merger with Viacom . The price target was also cut to $46 per share from $62 a share … The eye-care products company’s stock was rated “buy” at Goldman Sachs, citing strong organic revenue growth, among other factors. Goldman also set a price target of $67 per share compared to yesterday’s close of …

US STOCKS-Wall Street slips on political tensions, recession fears | Yahoo News | 8/12/2019

… elections in Argentina bolstered demand for safe-haven assets, including the Japanese yen, gold and U.S. Treasuries. Over the weekend, Goldman Sachs Group Inc said fears of the U.S.-China trade war leading to a … is seeking to launch a copycat version. CBS Corp and Viacom Inc are in the final stages of negotiating an all-stock merger that values Viacom at a discount to its closing price on Friday …

Medicare

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

… of its senior notes due 2024 and to repay borrowings under its revolving credit facility. Citigroup; Barclays; BofA Merrill Lynch; Goldman Sachs & Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust … information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health’s services by governmental or private payors; and other factors which may be identified …

Zocdoc’s new pricing rankles New York doctors | Crain’s New York Business | 8/27/2019

… since its 2007 founding has raised $223 million from such investors as Salesforce CEO Marc Benioff, Amazon CEO Jeff Bezos, Goldman Sachs and Khosla Ventures. Related Article Zocdoc’s CEO thinks you should be able to … so too. It has blocked users who say they are Medicare or Medicaid beneficiaries from booking visits through its site. But it is looking for a way to restore access to those users. “For over …

Wolfe Research

NetApp Inc (NTAP) Q1 2020 Earnings Call Transcript - Nasdaq.com | 8/15/2019

… Vice President, Corporate Communications and Investor Relations Thanks, Nehal. Next question. Operator Our next question comes from Rod Hall of Goldman Sachs. Your question please. Rod Hall – Goldman Sachs – Analyst Yeah, thanks for the question … Next question. Operator Next question comes for Andrew Vadheim of Wolfe Research. Your line is open. Andrew Vadheim – Wolfe Research – Analyst Thank you. I wanted to follow up on the full-year outlook. And what …

Edited Transcript of NCLH earnings conference call or presentation 8-Aug-19 2:00pm GMT | Yahoo News | 8/10/2019

Wolfe Research, LLC - Director & Senior Analyst Stephen White Grambling Goldman Sachs Group Inc., Research Division - Equity Analyst Steven Moyer Wieczynski Stifel, Nicolaus & Company, Incorporated, Research Division - MD of Equity Research and Gaming & Leisure Research Analyst Thomas Glassbrooke Allen Morgan Stanley, Research Division - Senior Analyst Presentation Operator [1] Good morning, and welcome to the Norwegian Cruise Line Holdings Second Quarter 2019 Earnings Conference Call. My name is Catherine and I’ll be …

Biotech

ObsEva SA to Participate in Upcoming Investor Conferences | Globe Newswire | 8/30/2019

August 30, 2019 01:00 ET Source: ObsEva SA Geneva, Switzerland and Boston, MA – August 30, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced that Company Management will be participating two upcoming investor conferences. The Goldman Sachs Ninth Annual Biotech Symposium taking place Friday, September …

ObsEva SA to Participate in Upcoming Investor Conferences | Markets Insider | Business Insider | 8/30/2019

Geneva, Switzerland and Boston, MA – August 30, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced that Company Management will be participating two upcoming investor conferences. The Goldman Sachs Ninth Annual Biotech Symposium taking place Friday, September 6, 2019 in London. The H.C. Wainwright 21 …

Digital Health

Health tech funding snapshot—Insurtech Ethos lands $60M in GV-led round, Nurx raises $52 million, and more | FierceHealthcare | 8/30/2019

… million in funding in a Series C round led by GV (formerly Google Ventures), Alphabet’s venture arm, and backed by Goldman Sachs, the company announced on August 27. The company, founded in 2016, is focused … round of funding to scale and hire new staff. RELATED: Digital health funding in first half of 2019 hits record $5.1B: report AI diagnoses: Buoy Health , an online symptom checker that uses artificial intelligence to …

Bond Raises $10 Million Seed Round to Accelerate the Pace of Financial Innovation | PR Newswire | 8/27/2019

… Matt Bradley , VP of Technology and Yan Wu , VP of Data Science & Operations. This trio are former executives from BlackRock, Goldman Sachs, SAP, SoFi, and Twilio, with expertise in developer platforms, fintech, artificial intelligence and … Canaan’s focus areas include fintech, SaaS, marketplace, e-commerce, biopharma, digital health and medtech. To learn more about our people and our portfolio, please visit canaan.com . About Coatue Coatue, founded by Philippe Laffont and Thomas …

Clinical Data

Breakthrough Genomics & EpigeneticsRx Partner to Further Functional Genomic Analysis and Innovations for the Medical Industry | PRWeb | 8/24/2019

Breakthrough Genomics & EpigeneticsRx Partner to Further Functional Genomic Analysis and Innovations for the Medical Industry Share Article Goldman Sachs has projected genomics to become a $5 trillion market globally, but most genetic data is not … focusing on a single mutation. The importance of using credible clinical data and having a reliable platform to analyze the data is a key component to improving patient care.” About EpigeneticsRx EpigeneticsRx’s secure platform is

Orchard Therapeutics plc (ORTX) CEO Mark Rothera on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/12/2019

… Officer Bobby Gaspar - Chief Scientific Officer Frank Thomas - Chief Financial Officer and Chief Business Officer Conference Call Participants Graig Suvannavejh - Goldman Sachs Anupam Rama - JP Morgan David Nierengarten - Wedbush Securities Operator Good day, ladies and … believe we have one of the most robust and comprehensive clinical data sets in the field of gene therapy. Now, turning to our recent news, last week, we were proud to announce that the FDA …

Medicaid

Zocdoc’s new pricing rankles New York doctors | Crain’s New York Business | 8/27/2019

… since its 2007 founding has raised $223 million from such investors as Salesforce CEO Marc Benioff, Amazon CEO Jeff Bezos, Goldman Sachs and Khosla Ventures. Related Article Zocdoc’s CEO thinks you should be able to … It has blocked users who say they are Medicare or Medicaid beneficiaries from booking visits through its site. But it is looking for a way to restore access to those users. “For over a year …

Mental Health

Health tech funding snapshot—Insurtech Ethos lands $60M in GV-led round, Nurx raises $52 million, and more | FierceHealthcare | 8/30/2019

… million in funding in a Series C round led by GV (formerly Google Ventures), Alphabet’s venture arm, and backed by Goldman Sachs, the company announced on August 27. The company, founded in 2016, is focused … according to TechCrunch . RELATED: Venture capital investment in AI and mental health startups surges in Q2: report Jobs marketplace: Nomad Health , an on-demand medical jobs marketplace that also advertises telemedicine positions, picked up $34 …

Zocdoc defends new pricing model as necessary for expansion as some N.Y. doctors criticize the changes | FierceHealthcare | 8/29/2019

… since its 2007 founding has raised $223 million from such investors as Salesforce CEO Marc Benioff, Amazon CEO Jeff Bezos, Goldman Sachs and Khosla Ventures, according to Crain’s New York Business. A Zocdoc spokesperson said … may now increase. RELATED: Venture capital investment in AI and mental health startups surges in Q2—report Under the change, physicians now pay an annual licensing fee that starts at $299, which covers account setup …

UnitedHealth

Boeing, Goldman Sachs share losses contribute to Dow’s 336-point drop - MarketWatch | 9/3/2019

The Dow Jones Industrial Average is seeing a selloff Tuesday morning with shares of Boeing and Goldman Sachs delivering the stiffest headwinds for the price-weighted average. The Dow DJIA, +0.77% was most recently trading … decline include Caterpillar CAT, +1.44% , Dow Inc. DOW, +0.77% , and UnitedHealth UNH, -0.50% . A $1 move in any one of the 30 components of the Dow results in a 6.78-point swing. Editor’s Note: This

Dow down 159 points on losses in shares of UnitedHealth, JPMorgan Chase - MarketWatch | 8/27/2019

Shares of UnitedHealth and JPMorgan Chase are retreating Tuesday afternoon, dragging the Dow Jones Industrial Average into negative territory. The Dow DJIA, -0.47% was most recently trading 159 points lower (-0.6%), as shares of UnitedHealth … Also contributing significantly to the decline are Boeing BA, -1.20% , Goldman Sachs GS, -0.79% , and American Express AXP, -0.66% . A $1 move in any of the index’s 30 components equates to a 6.78-point swing

Pfizer

Stocks To Trade In September | Forbes | 8/25/2019

… qualified. Six of seven declined for an average loss of 4.38%. The stocks ranged from -11.7% on the downside for Pfizer to a gain of 1.02% for JP Morgan. This approach is applied to September … show declining weekly cycles and are suitable short sales: Disney Goldman Sachs Intel General Electric Coca Cola Home Depot Honeywell Apple I add that the monthly cycle for the index does rise in September, so …

Boeing, JPMorgan Chase share gains lead Dow’s 132-point jump - MarketWatch | 8/22/2019

Goldman Sachs GS, +1.76% , and Pfizer PFE, +1.46% are also contributing significantly to the gain. A $1 move in any of the benchmark’s 30 components results in a 6.78-point swing. Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use …

Apple Health

The biggest differences between Apple’s new credit card and most other cards | Yahoo News | 8/28/2019

The Apple Card is officially available to consumers across the U.S., which means you can finally get your hands on one of your own. I’ve had the digital version of Apple’s ( AAPL ) card for a few weeks, and recently began using the physical card, and I’ve found it has a number of features of that make it more appealing than your average credit card. There’s the fantastic interface, the gorgeous …

Dow down nearly 50 points on losses for JPMorgan Chase, UnitedHealth stocks - MarketWatch | 8/27/2019

Shares of JPMorgan Chase and UnitedHealth are seeing declines Tuesday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow DJIA, -0.47% was most recently trading 46 points (0.2%) lower, as shares of JPMorgan Chase JPM, -1.06% and UnitedHealth UNH, -3.53% are contributing to the index’s intraday decline. JPMorgan Chase’s shares are down $1.43, or 1.3%, while those of UnitedHealth have fallen $3.08, or 1.3%, combining for an …

UnitedHealth Group

These stocks rose the most as Trump backed off (a bit) from tariffs - MarketWatch | 8/14/2019

… AAPL, -2.42% 4.2% 32.4% -10.5% Intel Corp. INTC, -2.23% 2.9% -0.1% -21.3% Dow Inc. DOW, -3.84% 2.5% N/A -22.6% UnitedHealth Group Inc. UNH, -1.30% 2.5% 0.0% -13.4% Cisco Systems Inc. CSCO, -3.03% 2.2% 21.5 … 23.8% -4.4% JPMorgan Chase & Co. JPM, -3.59% 1.3% 11.8% -8.5% Goldman Sachs Group Inc. GS, -3.86% 1.2% 22.1% -16.8% Exxon Mobil Corp. XOM, -3.14% 1.2% 3.3% -19.4% Visa Inc. Class A V, -2.54% 1.1% 35.2 …

These stocks are falling the most as Treasury yield curve inverts - MarketWatch | 8/14/2019

… 52-week high Dow Inc. DOW, +2.60% -5.9% N/A -27.2% Walgreens Boots Alliance Inc. WBA, +2.41% -5.0% -26.2% -41.6% Goldman Sachs Group Inc. GS, +1.65% -4.2% 17.1% -20.2% J.P. Morgan Chase & Co. JPM, +2.40 … 2.7% 9.3% -10.0% Pfizer Inc. PFE, +0.49% -2.7% -21.6% -26.3% UnitedHealth Group Inc. UNH, +0.59% -2.4% -2.4% -15.5% Johnson & Johnson JNJ, +0.63% -2.4% 0.9% -12.6% Intel Corp. INTC, +1.75% -2.1% -2.3% -23.0% McDonald’s Corp. MCD …

Siemens

Siemens Healthineers (ETR:SHL) Given a €34.00 Price Target by Goldman Sachs Group Analysts | 8/13/2019

Goldman Sachs Group set a €34.00 ($39.53) price target on Siemens Healthineers (ETR:SHL) in a research report sent Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock. DZ Bank reiterated a buy rating on shares of Siemens Healthineers in a report on Friday, May 3rd. Independent Research set a €38.50 ($44.77) price target on Siemens Healthineers and gave the company a neutral rating in a …

Siemens Healthineers (ETR:SHL) Given a €34.00 Price Target at Goldman Sachs Group - Ticker Report | 8/12/2019

Goldman Sachs Group set a €34.00 ($39.53) price objective on Siemens Healthineers (ETR:SHL) in a research report sent to investors on Thursday morning, Borsen brokerage currently has a neutral Other analysts also recently issued research reports about the stock. HSBC set a €41.00 ($47.67) target price on shares of Siemens Healthineers and gave the company research report on Friday, July 12th. Nord/LB set a €36.00 ($41.86) target price …

Merck

Stocks making the biggest moves premarket: Deere, Nvidia, GE, Facebook, Capital One & more | CNBC | 8/16/2019

Goldman Sachs, which also removed the apparel maker’s stock from its “Conviction Buy” list. That follows Tapestry’s earnings report in which the company said performance at its Coach unit was strong but that there are still issues with the Kate Spade brand. Merck – The drugmaker’s stock was rated “outperform” in new coverage at Leerink. The rating is based on optimism about expanded uses for the cancer drug Keytruda, among other …

These stocks rose the most as Trump backed off (a bit) from tariffs - MarketWatch | 8/14/2019

… 2.81% 1.6% -13.5% -25.0% Travelers Companies Inc. TRV, -2.13% 1.3% 23.8% -4.4% JPMorgan Chase & Co. JPM, -3.59% 1.3% 11.8% -8.5% Goldman Sachs Group Inc. GS, -3.86% 1.2% 22.1% -16.8% Exxon Mobil Corp. XOM, -3.14% 1.2 … 20.9% -10.8% Coca-Cola Co. KO, +0.52% 0.6% 12.9% -2.5% Merck & Co. Inc. MRK, -1.85% 0.5% 12.7% -1.1% Boeing Co. BA, -2.61% -0.1% 3.1% -25.4% Pfizer Inc. PFE, -1.72% -0.6% -19.4% -24.3% Source: FactSet You …

GlaxoSmithKline

GlaxoSmithKline (LON:GSK) PT Set at GBX 1,900 by Goldman Sachs Group | 9/7/2019

GlaxoSmithKline (LON:GSK) PT Set at GBX 1,900 by Goldman Sachs Group Posted by Ken Giver on Sep 7th, 2019 Tweet GlaxoSmithKline (LON:GSK) has been given a GBX 1,900 ($24.83) price objective by Goldman Sachs Group in a report issued on Friday, August 23rd, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. A number of other equities research analysts have also commented on GSK …

Goldman Sachs Group Analysts Give GlaxoSmithKline (LON:GSK) a GBX 1,900 Price Target | 8/26/2019

Goldman Sachs Group set a GBX 1,900 ($24.83) target price on GlaxoSmithKline (LON:GSK) in a research note released on Friday, Borsen Zeitung reports. The firm currently has a buy rating on the stock. A number of other research analysts also recently issued reports on the company. Bryan, Garnier & Co dropped their price target on GlaxoSmithKline from GBX 1,710 ($22.34) to GBX 1,660 ($21.69) and set a neutral rating on …

Siemens Healthineers

Siemens Healthineers (ETR:SHL) PT Set at €42.00 by Berenberg Bank | 7/16/2019

Siemens Healthineers (ETR:SHL) PT Set at €42.00 by Berenberg Bank July 15th, Siemens Healthineers (ETR:SHL) PT Set at €42.00 by Berenberg Bank - Filed Under - by Jeff Wilder Berenberg Bank set a €42.00 ($48.84 … objective on Siemens Healthineers research report on Thursday, July 11th. Goldman Sachs Group raised Altria Group from a neutral rating to a buy rating and set a $59.00 price objective for the company in a

Siemens Healthineers (ETR:SHL) Given a €41.00 Price Target at HSBC | 7/16/2019

Siemens Healthineers (ETR:SHL) Given a €41.00 Price Target at HSBC Posted by Eric Schroeder on Jul 16th, 2019 Tweet HSBC set a €41.00 ($47.67) price target on Siemens Healthineers (ETR:SHL) in a research … rating in a research note on Monday, May 6th. Finally, Goldman Sachs Group raised shares of Altria Group from a neutral rating to a buy rating and set a $59.00 target price for the company

Novartis

Goldman Sachs Group Analysts Give Novartis (VTX:NOVN) a CHF 105 Price Target - American Banking News | 9/13/2019

Posted by ABMN Staff on Sep 13th, 2019 // No Comments Novartis (VTX:NOVN) has been assigned a CHF 105 target price by investment analysts at Goldman Sachs Group in a report issued on Friday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. A number of other equities analysts also recently weighed in on NOVN. Deutsche Bank set a CHF 90 price target on Novartis and …

Goldman Sachs Group Reiterates CHF 105 Price Target for Novartis (VTX:NOVN) | 9/13/2019

Goldman Sachs Group Reiterates CHF 105 Price Target for Novartis (VTX:NOVN) Posted by Tristan Rich on Sep 13th, 2019 // Comments off Novartis (VTX:NOVN) received a CHF 105 price target from equities researchers at Goldman Sachs Group in a report issued on Friday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Several other analysts also recently weighed in on the company. JPMorgan Chase & Co …

Allergan

Red Rock Resorts stock price target cut to $26 from $36 at Instinet | MarketWatch | 8/26/2019

Goldman Sachs Group Inc, Sells Citigroup Inc, Allergan PLC, Yelp Inc Aug. 9, 2019 at 7:38 a.m. ET on GuruFocus.com In a report issued on August 6, Harry Curtis from Nomura maintained a Buy rating on Red Rock Resorts Inc (RRR), with a …[…] Aug. 8, 2019 at 10:19 a.m. ET on SmarterAnalyst Red Rock Resorts’ (RRR) impressive top-line performance in the second quarter 2019 can be attributed to a …

GOLDMAN SACHS: Recession fever has put hedge funds’ most beloved stock trades in the crosshairs of disaster. Here’s how to safeguard yourself from big losses. | Business Insider | 8/22/2019

… funds are crowding into a handful of stocks and increasing their use of leverage at the same time, according to Goldman Sachs. With recession fears at a fever pitch and market liquidity still scarce, hedge … The newest constituents of the so-called VIP basket include Allergan , Micron Technology , Zillow , and S&P Global . Get the latest Goldman Sachs stock price here …

Morgan Stanley

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

Goldman Sachs & Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act as joint book-running managers of the offering. This debt offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-220519) filed with the Securities and Exchange Commission. This offering is being made solely by means of a prospectus supplement …

Envista Announces Launch of IPO Roadshow | PR Newswire | 9/4/2019

Goldman Sachs & Co. LLC and Morgan Stanley are joint lead book-running managers for the offering. Baird, Evercore ISI and Jefferies are book-running managers for the offering. BofA Merrill Lynch, Credit Suisse, Stifel and William Blair are co-managers for the offering. The offering will be made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained from: J.P. Morgan Securities …

Citigroup

Kraft Heinz Announces the Expiration and Results for Tender Offer for Any and All 5.375% Senior Notes Due 2020 | Business Wire | 9/11/2019

Citigroup, Goldman Sachs & Co. LLC, and J.P. Morgan acted as Dealer Managers for the Offer. Global Bondholders Services Corporation served as the tender agent and information agent for the Offer. This press release is for informational purposes only and is not an offer to purchase, a solicitation of an offer to purchase or a solicitation of consents with respect to any securities. If any holder of the Notes is in …

Merrill Lynch

Kraft Heinz Announces the Expiration and Results for Tender Offer for Any and All 5.375% Senior Notes Due 2020 | Business Wire | 9/11/2019

Merrill Lynch, Citigroup, Goldman Sachs & Co. LLC, and J.P. Morgan acted as Dealer Managers for the Offer. Global Bondholders Services Corporation served as the tender agent and information agent for the Offer. This press release is for informational purposes only and is not an offer to purchase, a solicitation of an offer to purchase or a solicitation of consents with respect to any securities. If any holder of the Notes …

Jefferies Financial Group

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €80.00 Price Target at Goldman Sachs Group | 9/12/2019

Goldman Sachs Group set a €80.00 ($93.02) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Monday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock. FME has been the topic of a number of other reports. Jefferies Financial Group set a €68.00 ($79.07) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock …

AstraZeneca (LON:AZN) PT Raised to GBX 6,900 - Mayfield Recorder | 7/23/2019

Jefferies Financial Group reaffirmed a “buy” rating and set a C$15.00 target price on shares of Aphria in a research report on Friday, May 24th. Morgan Stanley upped their price target on SYSCO from $69.00 to $72.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 7th. Finally, Goldman Sachs Group raised to a “neutral” rating and dropped their price target for the …

RBC Capital Markets

Encompass Health announces launch of senior notes offering | PR Newswire | 9/9/2019

Goldman Sachs & Co. LLC; J.P. Morgan; Morgan Stanley; RBC Capital Markets; Regions Securities LLC; SunTrust Robinson Humphrey and Wells Fargo Securities will act as joint book-running managers of the offering. This debt offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-220519) filed with the Securities and Exchange Commission. This offering is being made solely by means of a prospectus supplement …

Canada Goose Holdings Inc. (GOOS) Q1 2020 Earnings Call Transcript - Nasdaq.com | 8/15/2019

… we don’t see changing. Omar Saad – Evercore ISI – Analyst Thank you. Operator Your next question comes from Kate Fitzsimons from RBC Capital Markets. Your line is open. Kate Fitzsimons – RBC Capital Markets – Analyst Yes, hi … product. Operator Your next question comes from Alexandra Walvis from Goldman Sachs. Your line is open. Rosalie Frazier – Goldman Sachs – Analyst Hi. This is Rosalie on behalf of Alex. On tourist spend, you mentioned strong …

JP Morgan

Stocks To Trade In September | Forbes | 8/25/2019

… average loss of 4.38%. The stocks ranged from -11.7% on the downside for Pfizer to a gain of 1.02% for JP Morgan. This approach is applied to September. The seasonal screen for the month is … show declining weekly cycles and are suitable short sales: Disney Goldman Sachs Intel General Electric Coca Cola Home Depot Honeywell Apple I add that the monthly cycle for the index does rise in September, so …

Berkshire Hathaway hires banks for SEC-registered yen bonds - Nasdaq.com | 8/19/2019

Shutterstock photo TOKYO, Aug 19 (IFR) - Berkshire Hathaway, rated Aa2/AA (Moody’s/S&P), has hired Goldman Sachs, JP Morgan, Bank of America Merrill Lynch and Mizuho for an SEC-registered yen-denominated benchmark bond issue. The Warren Buffett-led conglomerate hasn’t decided on the timing and the tenor of the issue, which will depend on market conditions. If the bond is sold in Japan, it would be limited to …

William Blair

Envista Announces Launch of IPO Roadshow | PR Newswire | 9/4/2019

Goldman Sachs & Co. LLC and Morgan Stanley are joint lead book-running managers for the offering. Baird, Evercore ISI and Jefferies are book-running managers for the offering. BofA Merrill Lynch, Credit Suisse, Stifel and William Blair are co-managers for the offering. The offering will be made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained from: J.P. Morgan Securities …

Now Isn’t the Time to Invest in General Electric Stock | Yahoo News | 8/21/2019

Goldman Sachs, Citigroup, and William Blair have all criticized the report . Plus, Markopolos is part of a hedge fund that stands to benefit financially from a declining GE stock price. This immediately hinders his credibility. But regardless of what happens with the report, it seems unlikely that General Electric stock is turning around anytime soon. Reasons to Hold Off on General Electric Stock In spite of the company’s restructuring efforts …

SunTrust Robinson Humphrey

American Equity Investment Life Holding Company (AEL) CEO John Matovina on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/10/2019

Goldman Sachs Group Inc. John Nadel - UBS Investment Bank Marcos Holanda - Raymond James & Associates, Inc. Pablo Singzon - JPMorgan Chase & Co. Mark Hughes - SunTrust Robinson Humphrey, Inc. Operator Hello and welcome to the American Equity Investment Life Holding Company’s Second Quarter 2019 Conference Call. At this time, for opening remarks and introductions, I will turn the call over to Julie LaFollette, Coordinator of Investor Relations. You may begin. Julie LaFollette Thank …

Valvoline Inc. (VVV) CEO Sam Mitchell on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/4/2019

Valvoline Inc. (NYSE: VVV ) Q3 2019 Earnings Conference Call August 1, 2019 9:00 AM Mary Meixelsperger - Chief Financial Officer Sam Mitchell - Chief Executive Officer Simeon Gutman - Morgan Stanley Faiza Alwy - Deutsche Bank Cody Ross - Goldman Sachs Mike Harrison - Seaport Global Securities, LLC Chris Bottiglieri - Wolfe Research Dmitry Silversteyn - Buckingham Research Olivia Tong - Bank of America Merrill Lynch Adam Bubes - Jefferies Stephanie Benjamin - SunTrust Robinson Humphrey Inc. Operator Good morning. My …

BlackRock

Bond Raises $10 Million Seed Round to Accelerate the Pace of Financial Innovation | PR Newswire | 8/27/2019

BlackRock, Goldman Sachs, SAP, SoFi, and Twilio, with expertise in developer platforms, fintech, artificial intelligence and data science. Ng is a seasoned software executive who was previously Twilio’s COO, and more recently President and COO of Mapbox. He also spent his early career in banking at Goldman Sachs. Bradley was previously a founding member and VP of Machine Learning at Synapse, EIR at the Founder Institute and holds a Ph.D …

The Power Of Purpose: Milton Friedman Is Rolling In His Grave | Forbes | 8/23/2019

… www.blackrock.com/corporate/investor-relations/larry-fink-ceo-letter” target=”_blank” class=”color-link” Larry Fink BlackRock letter /a . /p p Nearly 200 corporate leaders — from companies as diverse as Apple, AFLAC, American Airlines, Accenture, American Express, Amazon, Walmart, Walgreen, Johnson and Johnson, John Deere,Goldman Sachs, Home Depot, IPG, GM, Hearst, General Dynamics, Fedex, Fox, Deloitte, Dell, Coke, CVS, Chevron, Citigroup, Cisco, Cigna, Carlyle Group, Best Buy, AT&T …

J.P. Morgan Securities

Health Catalyst Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares | PR Newswire | 7/30/2019

… Health Catalyst’s common stock began trading on The Nasdaq Global Select Market under the symbol “HCAT” on July 25, 2019 . Goldman Sachs & Co. LLC, J.P. Morgan, and William Blair acted as joint book-running managers … telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected] ; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 866-803-9204, or by email at …

VC-backed Health Catalyst debuts IPO | PE Hub | 7/25/2019

… shares at $26 per share. The stock began trading July 25, 2019 on the NASDAQ under the ticker symbol “HCAT.” Goldman Sachs, J.P. Morgan and William Blair are the lead underwriters. Health Catalyst’s pre-IPO … NY 10282, telephone: 1-866-471-2526, or by email: [email protected]; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 1-866-803-9204, or by email: prospectus …

HCA

Fifteen Powerful And Innovative Women In Cannabis Right Now | Forbes | 8/27/2019

… and CEO for Women Grow. She is also the CEO and the owner of National Holistic™ a cannabis and hemp healthcare enterprise. Dr. Macias also expanded her footprint through Ilera Holistic Healthcare which partnered with … in the Corporate Communications department for fifteen years at the Goldman Sachs Group Inc. While at Goldman Sachs, Gia oversaw various business areas from Private Equity, Urban Investment, Investment Research and Technology to the firm’s …

Breakthrough Genomics & EpigeneticsRx Partner to Further Functional Genomic Analysis and Innovations for the Medical Industry | PRWeb | 8/24/2019

Breakthrough Genomics & EpigeneticsRx Partner to Further Functional Genomic Analysis and Innovations for the Medical Industry Share Article Goldman Sachs has projected genomics to become a $5 trillion market globally, but most genetic data is not … EpigeneticsRx’s platform is built on functional genomics, directed by licensed healthcare providers. The partnership capitalizes on EpigeneticsRx’s base of 25,000+ patients and 2,500+ healthcare professionals (HCP), as well as both companies’ years of experience in

HCA Healthcare

Ralph Lauren downgraded to sell from neutral at Goldman Sachs | MarketWatch | 7/17/2019

Levi Strauss cut to Sell at Goldman on elevated valuation vs. peers Jul. 17, 2019 at 9:04 a.m. ET on Seeking Alpha Softness in Ralph Lauren’s (RL) North America segment and adverse currency rates are hurting growth. But, the Next Great Chapter plan and strength in international and digital businesses bode well. Jul. 15, 2019 at 5:51 p.m. ET on Zacks.com Centre Asset Management, LLC Buys Philip Morris International Inc …

HCA Healthcare (NYSE:HCA) Upgraded to Buy by Goldman Sachs Group | 7/12/2019

HCA Healthcare (NYSE:HCA) Upgraded to Buy by Goldman Sachs Group Posted by Stephan Jacobs Jul 11th, 2019 Goldman Sachs Group upgraded shares of HCA Healthcare (NYSE:HCA) from a neutral rating to a buy rating in a research report sent to investors on Wednesday morning, 24/7 WallStreet reports. They currently have $160.00 price target on the stock, up from their previous price target of $147.00. A number of other …

Tenet Healthcare

Tenet To Spin-Off Conifer | Forbes | 8/7/2019

Deal Overview On July 24, 2019, Tenet Healthcare Corporation (NYSE: THC, $21.51, Market Capitalization: $2.23 billion) announced its intention to spin-off Conifer Health Solutions into an independent publicly traded company. Post spin-off, THC … and ticker are yet to be disclosed. THC has appointed Goldman Sachs & Co. LLC as financial advisor and Willkie Farr & Gallagher LLP as legal counsel to the transaction. Tenet and Price Performance Spin-Off Research

Tenet Healthcare stock jumps on plan to spinff Conifer unit - Business Insider | 7/24/2019

Tenet jumps as hospital company plans spinoff of health-services unit Conifer Clarrie Feinstein twitter Tenet Healthcare announced on Wednesday that its plan to pursue a spinoff of its Conifer business to be an independent … spinoff by the end of the second quarter of 2021. Goldman Sachs is the financial advisor on Tenet’s review of Conifer and Willkie Farr & Gallagher LLP is providing legal counsel. The company also said Conifer

Advocate Health Care

Advocate, Edward-Elmhurst hospital systems back away from Outcome Health | Chicago Tribune | 11/10/2017

… offices. The court filing indicates investors also anticipate inquiries from the Securities and Exchange Commission . The investors — including units of Goldman Sachs and Google and a fund co-founded by gubernatorial candidate J.B. Pritzker — sued … requests for comment. Earlier Thursday, representatives of Downers Grove-based Advocate Health Care and west suburban hospital system Edward-Elmhurst Health said they are pausing plans to expand their use of Outcome Health’s technology. The …

Outcome Health investors receive DOJ subpoenas as Chicago-area hospitals back away - Chicago Tribune | 11/10/2017

… offices. The court filing indicates investors also anticipate inquiries from the Securities and Exchange Commission . The investors — including units of Goldman Sachs and Google and a fund co-founded by gubernatorial candidate J.B. Pritzker — sued … requests for comment. Earlier Thursday, representatives of Downers Grove-based Advocate Health Care and west suburban hospital system Edward-Elmhurst Health said they are pausing plans to expand their use of Outcome Health’s technology. The …

CityMD

Meet the bankers involved in AbbVie’s $63 billion bid for Botox-maker Allergan | Business Insider | 6/25/2019

The deal would combine AbbVie, which makes the blockbuster drug Humira, with Allergan, which has been facing pressure from activists for more than a year to improve performance . Bankers from Morgan Stanley and PJT Partners, including former Goldman Sachs analyst Jami Rubin, advised AbbVie on the transaction, while JPMorgan advised Allergan. Click here for more BI Prime stories. Another massive pharmaceutical merger is underway. The $63 billion deal combines North …

Inside Slack’s direct listing; State Street goes toe-to-toe with BlackRock | Markets Insider | Business Insider | 6/22/2019

… listing, but all but three didn’t do anything besides providing research on the company, sources familiar told Business Insider. Instead, Goldman Sachs, Morgan Stanley, and Allen & Company will take a reported 90% of the fees … to create a huge new doctor group, combining $600 million CityMD with Summit Medical Group We’re at the start of a new era for marijuana-based medicine, according to the CEO behind the first prescription …

Edward-Elmhurst Health

Advocate, Edward-Elmhurst hospital systems back away from Outcome Health | Chicago Tribune | 11/10/2017

… offices. The court filing indicates investors also anticipate inquiries from the Securities and Exchange Commission . The investors — including units of Goldman Sachs and Google and a fund co-founded by gubernatorial candidate J.B. Pritzker — sued … Grove-based Advocate Health Care and west suburban hospital system Edward-Elmhurst Health said they are pausing plans to expand their use of Outcome Health’s technology. The company’s screens run educational content about health topics …

Outcome Health investors receive DOJ subpoenas as Chicago-area hospitals back away - Chicago Tribune | 11/10/2017

… offices. The court filing indicates investors also anticipate inquiries from the Securities and Exchange Commission . The investors — including units of Goldman Sachs and Google and a fund co-founded by gubernatorial candidate J.B. Pritzker — sued … Grove-based Advocate Health Care and west suburban hospital system Edward-Elmhurst Health said they are pausing plans to expand their use of Outcome Health’s technology. The company’s screens run educational content about health topics …

Dignity Health

Last Week’s Health Care Rout Shows That Politics Aren’t On The Back-Burner For Investors Like Some Had Thought | Kaiser Health News | 4/26/2019

… health-care stocks have shown that potential policy changes from the 2020 election are already on the minds of investors. Goldman Sachs Group Inc. has a few ideas about how to navigate such a tricky … In the more than two years Catholic Health Initiatives and Dignity Health worked to cement their merger to form the new Chicago-based health system, both systems avoided public debt markets. This week, CommonSpirit announced …

SuperReturn US West Returns to San Francisco February 12-14 | Morningstar | 1/22/2018

Goldman Sachs & Co Scott Kupor, Managing Partner, Andreessen Horowitz Aaron Gershenberg, Founder and Managing Partner, Silicon Valley Bank Capital Lindsay Larsen, Managing Director, UVIMCO Doug Tapley, Director, KKR Julia Winterson, Director, Investments, Dignity Health Andrea Auerbach, Managing Director, Head of Global Private Investments, Cambridge Associates Kevin McDowell, Managing Director, Alberta Teachers’ Retirement Fund “We are very pleased to once again host SuperReturn US West in San Francisco, bringing together a …

MD Anderson Cancer Center

Pure Storage, Inc. (PSTG) CEO Charlie Giancarlo on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/22/2019

… Pinjalim Bora - JPMorgan Jason Ader - William Blair Karl Ackerman - Cowen Andrew Nowinski - Piper Jaffray Katy Huberty - Morgan Stanley Rod Hall - Goldman Sachs Steven Fox - Cross Research Simon Leopold - Raymond James Eric Martinuzzi - Lake Street Matt … quarter, U.K. Ministry of Defense and the University of Texas MD Anderson Cancer Center have both chosen FlashBlade, signaling excitement around our flash-to-flash-to-cloud architecture and rapid restore use case. This is …

Pure Storage, Inc. (PSTG) Q1 2019 Earnings Call Transcript - Nasdaq.com | 5/22/2019

… to gain better insight into their data. And finally, this quarter, UK Ministry of Defense and the University of Texas MD Anderson Cancer Center have both chosen FlashBlade, signaling the excitement around our flash-to … you. Operator Your next question comes from Rod Hall from Goldman Sachs. Rod Hall – Goldman Sachs – Analyst Yeah. Hi, guys. Thanks for the question. I just have five, I’m actually kidding. So, I wanted to …

Acadia Healthcare

Following DOJ Fraud Settlement, Revelations From A Careful Look At Acadia Healthcare’s Earnings - Acadia Healthcare Company, Inc. (NASDAQ:ACHC) | Seeking Alpha | 5/29/2019

Acadia Healthcare Inc. (NASDAQ: ACHC ) is, in my belief, implementing very creative tactics to (appear to) make money. Additionally, an insurance company executive corroborated early suspicions, as well as an ex-staff member allegation that … 74,017 NEUBERGER BERMAN GROUP LLC 03/31/2019 1,658,751 782,480 89.30 54,606 GOLDMAN SACHS GROUP INC 03/31/2019 1,627,551 (660,819) (28.88) 53,579 JANUS HENDERSON GROUP PLC 03/31/2019 1,513,558 3,508 .23 49,826 FIRST TRUST ADVISORS LP 03/31/2019 1,501,316 156,081

Wall Street Sunday Breakfast: Stocks To Watch | Seeking Alpha | 5/26/2019

… price, although Beyond Meat’s (NASDAQ: BYND ) analyst quiet period expiration on May 28 is going to put underwriters Credit Suisse, Goldman Sachs, JPMorgan, BAML, Jefferies and William Blair on the hook. Shares of Beyond Meat … has its annual meeting scheduled for May 31. Business calls: Acadia Healthcare (NASDAQ: ACHC ) will provide an update on May 30 regarding strategy and its future direction. Sports betting: West Virginia could see live mobile …

St. Joseph Health

Here’s how Microsoft is using healthcare partnerships to buoy its cloud services | Business Insider | 7/9/2019

… Intelligence Digital Health Pro subscribers. To receive the full story plus other insights each morning, click here . Microsoft and Providence St. Joseph Health announced a multiyear strategic partnership that will lean on the tech company’s … Microsoft coming in second at a projected 22%, per a Goldman Sachs report provided to Business Insider. But competition to control the cloud market is likely to be fierce, as Amazon is also ramping up …

After $14M Series A funding round, Providence spinoff Xealth plans to grow | The Business Journals | 7/5/2019

St. Joseph Health spinout is also moving up a few floors in Seattle’s first skyscraper, Smith Tower , which Goldman Sachs recently purchased. That’s not to accommodate growth, but to keep leasing costs affordable, McSherry said. Xealth will take over EnergySavvy’s lease on the 19th floor. The Seattle-based startup digitally facilitates health care between the provider and the patient. Already, it’s working with seven of the 10 largest hospitals in …

Aetna

H2O raises $72.5 million to simplify enterprise AI deployment | VentureBeat | 8/20/2019

Aetna, Booking.com, Comcast, Hitachi, Nationwide Insurance, PwC, and Walgreens, actively use H2O’s data science tools. In perhaps another sign of the industry’s upward momentum, H2O today announced that it has raised $72.5 million in a round led by Goldman Sachs and the Ping An Global Voyager fund, with continued investments from Wells Fargo and Nexus Venture Partners. Jade Mandel from Goldman Sachs will join H2O’s board of directors as part …

H2O.ai Raises $72.5M Led by Goldman Sachs and Ping An to Democratize AI | PR Newswire | 8/20/2019

… secured $72.5 million in a Series D round, bringing the total funding to $147 million . The round was led by Goldman Sachs ( NYSE: GS ) and the Ping An Global Voyager Fund ( OTCMKTS: PNGAY) with continued … of H2O.ai are becoming AI companies including leaders such as Aetna, Booking.com, Capital One, Comcast, Commonwealth Bank of Australia , Franklin Templeton , Hitachi, MarketAxess, Nationwide Insurance, PwC, Tokio Marine, Wells Fargo and Walgreens, leading AI transformations …

Cigna

The Power Of Purpose: Milton Friedman Is Rolling In His Grave | Forbes | 8/23/2019

Goldman Sachs, Home Depot, IPG, GM, Hearst, General Dynamics, Fedex, Fox, Deloitte, Dell, Coke, CVS, Chevron, Citigroup, Cisco, Cigna, Carlyle Group, Best Buy, AT&T, Boeing, Bristol Myers-Squibb, Bank of America, Blackrock, United Airlines, UPS, Tishman Speyer, Steeelcase, Target, P&G, SAP, Qualcomm, Phizer, PWC, Salesforce, PepsisCo, Oracle, Metlife, Morgan Stanley, Mastercard, Macys, Mass Mutual, JP Morgan Chase, Marriott, KPMG, Visa, Xerox, 3M and many more — declared …

Goldman Sachs recommends two stock-picking strategies amid the US-China trade war | Yahoo News | 8/12/2019

… between the U.S. and China heat up with the market bracing for a new round of tariffs on Sept. 1, Goldman Sachs strategists are recommending a few strategies for asset managers to navigate the uncertainty … are also service-focused companies, including: Netflix ( NFLX ), PayPal ( PYPL ), Cigna ( CI ), Aflac ( AFL ) and McKesson ( MCK ). The recent escalation of the trade war with China has sparked stock market volatility over the past week …

Humana

How WeWork Incentivized CEO Adam Neumann to Take the Company Public: Term Sheet | Fortune | 8/15/2019

… round led by early-stage venture capital firm Canvas Ventures, as well as $120 million in debt from lenders including Goldman Sachs-backed Genesis Capital. Read more at Fortune. 100 FASTEST-GROWING COMPANIES: Fortune’s annual … Ventures led the round, and was joined by investors including Humana , F-Prime and Optum Ventures. HEALTH & LIFE SCIENCES DEALS – Renovacor , a Philadelphia-based preclinical-stage biopharmaceutical company, raised $11 million in a Series A …

Anthem

Health-Insurer Rout Finished Long Before 2020 Vote, Goldman Says | Yahoo News | 4/17/2019

Anthem Inc., UnitedHealth Group Inc., Centene Corp. and Humana Inc. The benchmark is now down 13 percent for the year, significantly underperforming the broader market. Despite slashing their price targets on industry bellwether UnitedHealth as political concerns outweighed an earnings beat, some analysts – chief among them those at Goldman Sachs – remain optimistic that the sell-off will stop well before November 2020. “This moment in time is not unprecedented,” Goldman’s …

UnitedHealthcare

UnitedHealth Group Incorporated (UNH) CEO David Wichmann on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/18/2019

UnitedHealthcare Andrew Witty - CEO, Optum John Rex - CFO Eric Murphy - CEO, OptumInsight Brian Thompson - CEO, Medicare & Retirement Tom Roos - SVP and Chief Accounting Officer Conference Call Participants Justin Lake - Wolfe Research Charles Rhyee - Cowen Josh Raskin - Nephron Research Matthew Borsch - BMO Capital Markets David Windley - Jeffries Kevin Fischbeck - Bank of America Ricky Goldwasser - Morgan Stanley Steve Tanal - Goldman Sachs A.J. Rice - Credit Suisse Peter Costa - Wells Fargo Securities Sarah James …

Oxford qualifies for $132 million risk-adjustment award in small-group market | Crain’s New York Business | 7/3/2019

… Affordable Care Act’s risk adjustment program has once again made winners and losers out of New York’s health insurers, with UnitedHealthcare’s Oxford continuing to reap the biggest bounty. Based on the risk of members last … vice president on the private wealth global management team of Goldman Sachs. Chad Shearer has been named senior vice president for policy and program at United Hospital Fund. He previously served as vice president for …

Health Net

OneFifteen Opens the First of its State-of-the-Art Facilities for the Treatment of Opioid Use Disorder in Dayton, Ohio | PR Newswire | 6/14/2019

… within its state-of-the-art campus today in Dayton, Ohio . OneFifteen, which was launched earlier this year by Kettering Health Network, Premier Health, and Verily, also welcomed Natalie Lester , M.D., M.P.H., M.B.A. as medical … leaders by enabling OneFifteen’s partnerships with other organizations, such as Goldman Sachs 10,000 Small Businesses, that share the goal of working towards a brighter future for Dayton .” “Once known for its legacy of innovation, in …

The science behind OneFifteen’s addiction treatment program | The Business Journals | 6/14/2019

… financed by Google’s sister company Verily in California, a life sciences research organization, and the local Premier Health and Kettering Health Network. The nonprofit OneFifteen is “a robust response to the opioid epidemic, the No … c)(3) that coordinates community-based, wrap-around services. Related : Goldman Sachs to open regional hub in Dayton, collaborate with OneFifteen Schlosser said the program will not only offer the full continuum of care, but …

Wellcare

Hedge funds are dumping tech stocks for health care | CNBC | 8/21/2019

… hedge funds are steering away from battered tech and semiconductor stocks, while bottom fishing in health-care names, according to Goldman Sachs. The fast money continued its rotation from tech to health care, according to … top new holdings are pharmaceutical company Allergan , insurers Centene , Humana , WellCare Health Plans and Walgreens , according to Goldman. Centene and Walgreens both lost more than 25% in the past six months. Hedge funds are “largely …

Goldman Closes Above 210; Breakout Confirmed - Square And Others In Breakout Bonanza | Seeking Alpha | 7/12/2019

… 2.3%, perhaps 2.5%. That differential will help the financial sector make more money. As previously noted, the charts showed that Goldman Sachs (NYSE: GS ) should accelerate to the upside if it were to close above … the 52-week high is 74.5. CNC is acquiring the WellCare Group, which should close in the first half of 2020. I think there are still some points to be scalped here. Head on a …

Centene Corp

Centene’s (CNC) CEO Michael Neidorff on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/23/2019

Centene Corporation (NYSE: CNC ) Q2 2019 Earnings Conference Call July 23, 2019 8:30 AM ET Company Participants Ed Kroll – Investor Relations Michael Neidorff – Chairman, President and Chief Executive Officer Jeff Schwaneke – Executive Vice President and … Piper Jaffray Lance Wilkes – Bernstein Matt Borsch – BMO Steve Tanal – Goldman Sachs Dave Windley – Jefferies Peter Costa – Wells Fargo Peter Costa – Wells Fargo A.J. Rice – Credit Suisse Gary Taylor – JPMorgan Justin Lake – Wolfe Research Ralph

Barron’s All-Stars Sniff Out Bargains in Sky-High U.S. Market | Yahoo News | 7/14/2019

… 30 a year ago, and TriplePoint Venture Growth BDC Corp., a diversified investment company.Abby Joseph Cohen, senior investment strategist at Goldman Sachs Group Inc., says the U.S.-China trade war is contributing to lower capital … mid-year picks included gaming company MGM Resorts International and Centene Corp., a health insurer active in Medicaid and the Obamacare exchanges. (Updates with Witmer, Priest picks in final bullets.) To contact the reporter on …

The Health Plan

Evolent Health, Inc. (EVH) CEO Frank Williams on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/8/2019

… Participants Frank Williams - Co-Founder, CEO & Chairman Nicholas McGrane - CFO Conference Call Participants Ryan Daniels - William Blair & Company Robert Jones - Goldman Sachs Group James Stockton - Wells Fargo Securities Sean Wieland - Piper Jaffray Companies Anne Samuel … in all aspects of operations in an effort to insulate the health plan as much as possible from potential rate volatility in the future. These improvements are needed in addition to the recent rate increase …

Cigna Corporation (CI) CEO David Cordani on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/2/2019

… Scott Fidel - Stephens David Stybloin - Jefferies Josh Raskin - Nephron Research Steven Valiquette - Barclays Matt Borsch - BMO Capital Markets Steve Tanal - Goldman Sachs Ralph Giacobbe - Citigroup Ana Gupte - SVB Leerink Zach Sopcak - Morgan Stanley Peter Costa … Health Service business and the client portfolio, essentially think about the health plan portion that portfolios complete. And think about the commercial portion of that portfolios completing. So there could be some variability in the …

Wellcare Health Plans

Hedge funds are dumping tech stocks for health care | CNBC | 8/21/2019

… hedge funds are steering away from battered tech and semiconductor stocks, while bottom fishing in health-care names, according to Goldman Sachs. The fast money continued its rotation from tech to health care, according to … top new holdings are pharmaceutical company Allergan , insurers Centene , Humana , WellCare Health Plans and Walgreens , according to Goldman. Centene and Walgreens both lost more than 25% in the past six months. Hedge funds are “largely …

Centene and WellCare Stockholders Approve Proposals Regarding Centene’s Pending Acquisition of WellCare | Markets Insider | Business Insider | 6/24/2019

ST. LOUIS and TAMPA, Fla. , June 24, 2019 /PRNewswire/ – Centene Corporation (NYSE: CNC) (“Centene”) and WellCare Health Plans, Inc. (NYSE: WCG) (“WellCare”) today announced that the stockholders of both companies approved all proposals regarding Centene’s … Slate, Meagher & Flom LLP is serving as its legal counsel. Goldman Sachs is serving as financial advisor to WellCare and Kirkland & Ellis LLP and Locke Lord LLP are serving as legal counsel. About Centene Centene

Donald Trump

Stock market news: August 27, 2019 | Yahoo News | 8/27/2019

… not confirmed to media that phone calls between U.S. and Chinese trade negotiators took place over the weekend, as President Donald Trump had said occurred. China’s Foreign Ministry spokesperson said Tuesday he was “not aware … analysts have underscored new ways for investors to seek refuge. Goldman Sachs analysts led by David Kostin highlighted three main strategies for investors to position themselves amid trade uncertainty: look to services-providing companies, domestic …

Jamie Dimon

Barra, Hackett, Fitterling join CEO group saying shareholder value isn’t ultimate yardstick | Crain’s Detroit Business | 8/19/2019

Jamie Dimon and dozens of other leaders at some of the world’s largest companies — including General Motors Co. Chairman and CEO Mary Barra, Ford Motor Co. President and CEO James Hackett, and Dow Chemical Co … Scharf and the CEOs of several Wall Street banks, including Goldman Sachs Group Inc., Morgan Stanley and Moelis & Co. It also includes Amazon.com Inc. founder Jeff Bezos, the world’s richest person. Other Michigan signatories include

Goldman Sachs recommends two stock-picking strategies amid the US-China trade war | Yahoo News | 8/12/2019

… between the U.S. and China heat up with the market bracing for a new round of tariffs on Sept. 1, Goldman Sachs strategists are recommending a few strategies for asset managers to navigate the uncertainty … WMT ). Berkshire Hathaway CEO Warren Buffett and JPMorgan Chase CEO Jamie Dimon. (Getty Images) More Labor costs As Yahoo Finance reported last week , Goldman Sachs now expects 75bp worth of rate cuts in 2019, including …

Warren Buffett

Berkshire Hathaway hires banks for SEC-registered yen bonds - Nasdaq.com | 8/19/2019

Shutterstock photo TOKYO, Aug 19 (IFR) - Berkshire Hathaway, rated Aa2/AA (Moody’s/S&P), has hired Goldman Sachs, JP Morgan, Bank of America Merrill Lynch and Mizuho for an SEC-registered yen-denominated benchmark bond issue. The Warren Buffett-led conglomerate hasn’t decided on the timing and the tenor of the issue, which will depend on market conditions. If the bond is sold in Japan, it would be limited to …

Cramer not worried about the yield curve, says Buffett is buying banks | CNBC | 8/14/2019

Jim Cramer is not worried about the yield curve, says Warren Buffett is buying bank stocks Published Wed, Aug 14 2019 9:55 AM EDT Updated Wed, Aug 14 2019 1:03 PM EDT Jesse Pound @jesserpound … in several financial firms, including American Express , Bank of America , Goldman Sachs and J.P. Morgan , according to his most recent shareholder letter. In a later interview, Cramer cited Germany’s negative-yielding government bonds and the

Rishi Shah

Grand jury probes alleged fraud at Outcome Health | Modern Healthcare | 7/26/2019

Rishi Shah and Shradha Agarwal, were darlings of the Chicago startup tech community. Growth took off in 2015 and 2016, and in early 2017 it raised nearly $500 million from A-list investors, including Goldman Sachs, Google and Pritzker Group Venture Capital. Investors sued the founders for fraud after the Wall Street Journal reported allegations by advertisers of inflated numbers. Investors soon disclosed they’d received subpoenas from the U.S. Department …

FBI targeted Outcome Health and its co-founders in fraud probe, affidavit shows: report | FiercePharma | 7/26/2019

… a briefly unsealed affidavit for a search warrant reported by the Chicago Tribune. Citing “probable cause to believe” co-founders Rishi Shah and Shradha Agarwal committed mail and wire fraud, federal agents at that time … company “remains fully cooperative,” McNally said. In November 2017, investors Goldman Sachs, Leerink Transformation Partners, the Pritzker Group, Norwest Venture Partners, Balyasny Asset Management and Prudence Outcome Holdings said they had received subpoenas from the …

Shradha Agarwal

Grand jury probes alleged fraud at Outcome Health | Modern Healthcare | 7/26/2019

Shradha Agarwal, were darlings of the Chicago startup tech community. Growth took off in 2015 and 2016, and in early 2017 it raised nearly $500 million from A-list investors, including Goldman Sachs, Google and Pritzker Group Venture Capital. Investors sued the founders for fraud after the Wall Street Journal reported allegations by advertisers of inflated numbers. Investors soon disclosed they’d received subpoenas from the U.S. Department of Justice. Once …

FBI targeted Outcome Health and its co-founders in fraud probe, affidavit shows: report | FiercePharma | 7/26/2019

… affidavit for a search warrant reported by the Chicago Tribune. Citing “probable cause to believe” co-founders Rishi Shah and Shradha Agarwal committed mail and wire fraud, federal agents at that time asked to search … company “remains fully cooperative,” McNally said. In November 2017, investors Goldman Sachs, Leerink Transformation Partners, the Pritzker Group, Norwest Venture Partners, Balyasny Asset Management and Prudence Outcome Holdings said they had received subpoenas from the …

Tim Cook

Is Apple iPhoning the Finance Industry? | Yahoo News | 8/20/2019

… to it More Image source: Apple Trolling its e-payment competitors During the company’s fiscal 2019 third-quarter report, CEO Tim Cook cited electronic payments giant PayPal (NASDAQ: PYPL) when touting the growth of Apple … any kind. As the partner issuing bank, that will keep Goldman Sachs ‘ profits in check. Cash back rewards will accrue daily rather than monthly, the typical credit card industry standard. Spending will also be tracked …

US STOCKS-Futures jump on growing stimulus hopes | Yahoo News | 8/19/2019

… market rally easing, interest-rate sensitive lenders rose in premarket trading. Bank of America Corp, Citigroup Inc, JPMorgan Chase & Co, Goldman Sachs , Wells Fargo & Co and Morgan Stanley were all up between 1.5% and 2 … on Sunday that he had spoken with Apple Chief Executive Tim Cook about the impact of U.S. tariffs. (Reporting by Medha Singh in Bengaluru Editing by Saumyadeb Chakrabarty …

Elon Musk

10 things in tech you need to know today | Business Insider | 8/12/2019

… Video game streamer Ninja. Getty Good morning! This is the tech news you need to know this Friday. Tesla CEO Elon Musk said he supports Democratic presidential candidate Andrew Yang, calling universal basic income “obviously … for Apple’s new credit card . The bank behind the card, Goldman Sachs, has been approving users for the card who have “subprime” credit scores at the direction of Apple, CNBC reported. President Trump told reporters …

10 things in tech you need to know today | Markets Insider | Business Insider | 8/12/2019

Getty Good morning! This is the tech news you need to know this Friday. Tesla CEO Elon Musk said he supports Democratic presidential candidate Andrew Yang, calling universal basic income “obviously needed.” Yang is a … for Apple’s new credit card . The bank behind the card, Goldman Sachs, has been approving users for the card who have “subprime” credit scores at the direction of Apple, CNBC reported. President Trump told reporters

Jeff Bezos

Zocdoc’s new pricing rankles New York doctors | Crain’s New York Business | 8/27/2019

Jeff Bezos, Goldman Sachs and Khosla Ventures. Related Article Zocdoc’s CEO thinks you should be able to see a doctor within 24 hours Some doctors have voiced frustration but have stuck with the platform. Major groups with hundreds of physicians, including NYU Langone and Tarrytown-based ENT & Allergy Associates, have stopped using the service. An NYU Langone spokeswoman said the health system’s contract with Zocdoc had ended, and it decided …

Bernie Sanders

Former Brexit negotiator Olly Robbins to join Goldman Sachs (Financial Times) | 9/10/2019

Sydney Ember / New York Times : Bernie Sanders Went to Canada, and a Dream of ‘Medicare for All’ Flourished — The Vermont senator has staked his presidential campaign, and much of his political legacy, on transforming health care in America. His mother’s illness, and a trip he made to study the Canadian system, help explain why. Financial Times : Former Brexit negotiator Olly Robbins to join Goldman Sachs — Olly Robbins, the civil servant …

Kamala Harris raises $1 million at Hamptons, Martha’s Vineyard fundraisers | CNBC | 8/22/2019

Bernie Sanders. She raised $12 million last quarter while the front runner Biden raised just over $21.5 million . Even while trailing in the fundraising race, Harris still has been finding ways to reel in donors from Wall Street. She, along with Biden and Buttigieg, saw donations from at least 15 executives from from the biggest banks . Goldman Sachs ‘ Jennifer Scully-Lerner gave Harris $1,000 in late June . McGuire sent $2,800 …

Dara Khosrowshahi

5 things to know before the stock market opens August 9, 2019 | CNBC | 8/9/2019

… bill first rising above that of the 10-year note in March. 3. Uber sinks after reporting a disappointing quarter Dara Khosrowshahi, CEO of Uber Technologies, speaks during an Economic Club of Washington event in … Valley companies as a price of luring top talent. 5. Goldman Sachs dips into subprime with Apple Card Apple CEO Tim Cook introduces Apple Card during a launch event at Apple headquarters on March 25 …

Slew of local companies prep to go public | Crain’s New York Business | 7/8/2019

… the current guess is that it will be valued around $8 billion. Comcast is a major investor, and Uber CEO Dara Khosrowshahi was one of its angels. It has raised about $1 billion in venture … and casualty insurance company, reportedly has tapped JPMorgan Chase and Goldman Sachs to plan a stock offering by the end of the year to raise as much as $500 million. Peer-to-peer insurance is …